Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease.
about
Risk Factors for Death of Patients with Cystic Fibrosis Awaiting Lung TransplantationCurrent status of paediatric heart, lung, and heart-lung transplantationLung transplantation in chronic obstructive pulmonary disease: patient selection and special considerationsPositioning new pharmacotherapies for COPDIdiopathic pulmonary fibrosis: diagnostic pitfalls and therapeutic challengesSelecting lung transplant candidates: where do current guidelines fall short?Lung transplantation for cystic fibrosisCritical care aspects of lung transplantation.Lung transplantation: a decade of experience.Survival benefit of lung transplant for cystic fibrosis since lung allocation score implementation.Recent advances: Respiratory medicine.Risk factors and outcomes for the development of malignancy in lung and heart-lung transplant recipients.Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model.Racial and ethnic disparities in idiopathic pulmonary fibrosis: A UNOS/OPTN database analysisBurkholderia cepacia complex: a contraindication to lung transplantation in cystic fibrosis?Elevated pulmonary artery pressure is a risk factor for primary graft dysfunction following lung transplantation for idiopathic pulmonary fibrosis.Ethical issues in thoracic organ distribution for transplant.Disorders of the respiratory muscles.Delayed access and survival in idiopathic pulmonary fibrosis: a cohort studyInduced sputum cell profiles in lung transplant recipients with or without chronic rejection: correlation with lung functionIntrathoracic organ transplantation in the United Kingdom 1995-99: results from the UK cardiothoracic transplant audit.Impact of the lung allocation score on survival beyond 1 year.Lung transplant in end-staged chronic obstructive pulmonary disease (COPD) patients: a concise reviewThoracic organ transplantation.Surrogate markers and risk factors for chronic lung allograft dysfunction.Beyond survival: the burden of disease in decision making in organ transplantation.Targeted Antibiotic Prophylaxis for Lung Transplantation in Cystic Fibrosis Patients Colonised with Pseudomonas aeruginosa Using Multiple Combination Bactericidal Testing.Pulmonary fibrosis: rate of disease progression as a trigger for referral for lung transplantation.What Is the Optimal Transplant for Older Patients With Idiopathic Pulmonary Fibrosis?Racial differences in waiting list outcomes in chronic obstructive pulmonary disease.Pirfenidone for the treatment of idiopathic pulmonary fibrosis.Morphometric examination of native lungs in human lung allograft recipients.Transplantation in chronic obstructive pulmonary disease.Mortality and functional performance in severe emphysema after lung volume reduction or transplant.Hypoalbuminemia and early mortality after lung transplantation: a cohort studyInterstitial pneumonitis and the risk of chronic allograft rejection in lung transplant recipientsLung transplantation and survival in children with cystic fibrosisSurvival effect of lung transplantation among patients with cystic fibrosisChanging the burden of COPD mortalityDisparities in lung transplantation before and after introduction of the lung allocation score
P2860
Q22306317-DEB42EFC-514C-44B8-88F2-B39769570A40Q24675133-11D9C31C-4110-47C2-B087-2CC94E5158FCQ26778492-867DF2A8-21C4-40A7-BA43-D5A496425A89Q26798659-2A4DCF6F-806C-4FB2-867C-8055DEC26812Q27499290-119B360C-0D23-417E-843B-3138550E74AAQ28731766-860E4775-F554-4D43-B192-7094FB9DC20CQ28749501-BD81B93F-3434-46B6-90A2-6A960D6F5328Q33360317-AF8708ED-66BB-4EF7-B9D6-A57761AD76B1Q33736447-762CEBAE-4810-4E64-8A65-F39C0FC9ED08Q33738670-890CE7DF-207C-4957-8289-C98731D6B21BQ33808282-9C54A853-3F28-4947-874C-F27A1EF8CD71Q33836119-143AE0BF-8D37-4472-ADCD-06F5754BD610Q33955628-97EADF11-43BA-4778-8F6C-7AF072D8BBC8Q34129022-F96E6357-6203-465B-B69C-98E1DABA05C2Q34330072-663B2001-C935-417B-9415-A7570902EC20Q34764561-3106B660-4287-47D4-B85F-61E1CF6D4233Q35106635-6B687C20-BBAA-448A-9E04-F0BE4D61E045Q35162640-A1088450-B1BE-4AAC-8903-9F4737BC977DQ35528347-EED6D0F8-2D8B-463E-8CE4-735C45EDDD96Q35534596-E04A375A-C9F1-4267-9886-EDC5DD29AE5FQ35579949-15175494-9708-4E15-8720-9F18DACFC3BCQ35596192-979FCD88-6F4B-4A93-AD3B-4A5FAD5990C6Q35667648-DBD81C74-B6BA-4DDF-9870-A6F75FE1FEB1Q35758298-9650CB8D-1D62-4CFE-9093-71ACBFD5B502Q35804373-EC2CD064-AB4A-4512-9296-C35781E6129EQ35887499-E7B5079A-55C2-4BA5-9DDE-192CEA30FEC7Q36118861-63350D61-737C-4029-BBF6-7787DA2D8416Q36169122-F02AC4C5-0B15-465D-95E4-E8A5D0691657Q36240531-70F68D2D-16D7-49E2-9149-F42620C2F341Q36482635-B6028A39-41B8-4C07-A282-742E3411BF31Q36512577-888210E8-6197-4B14-9BE2-CBF27B57C964Q36641587-444BE644-892D-4EBA-BB48-9BAFA30CE952Q36714246-561247A9-9FA4-46DD-983E-C02DBF08FA7FQ36761463-553CA5F9-7314-4EC4-8B01-F26AF09A57A2Q36773622-FF792A3C-D02B-4B35-AC86-6C55B20A8F52Q36842016-7881C8B8-09C6-44F8-91A4-B0C163B3A880Q36848748-553FE0CF-A200-43F9-9292-5FDA0CCEB826Q36848757-0A0F3190-5196-4564-84D8-B8C2F298CEB5Q37018812-A52644D7-09F9-4C60-91F5-55712A3A0A9BQ37021756-625A6DA0-2FE6-496B-AC6C-D244D3E9407D
P2860
Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease.
description
1998 nî lūn-bûn
@nan
1998 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Effect of diagnosis on surviva ...... on for end-stage lung disease.
@ast
Effect of diagnosis on surviva ...... on for end-stage lung disease.
@en
Effect of diagnosis on surviva ...... on for end-stage lung disease.
@nl
type
label
Effect of diagnosis on surviva ...... on for end-stage lung disease.
@ast
Effect of diagnosis on surviva ...... on for end-stage lung disease.
@en
Effect of diagnosis on surviva ...... on for end-stage lung disease.
@nl
prefLabel
Effect of diagnosis on surviva ...... on for end-stage lung disease.
@ast
Effect of diagnosis on surviva ...... on for end-stage lung disease.
@en
Effect of diagnosis on surviva ...... on for end-stage lung disease.
@nl
P2093
P1433
P1476
Effect of diagnosis on surviva ...... on for end-stage lung disease.
@en
P2093
E B Edwards
J D Hosenpud
L E Bennett
R J Novick
P356
10.1016/S0140-6736(97)06405-2
P407
P577
1998-01-01T00:00:00Z